These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22072265)

  • 1. Histopathologic markers of hearing loss in intralabyrinthine schwannomas: implications for management.
    Santos F; Linthicum FH; House JW; Wilkinson EP
    Otol Neurotol; 2011 Dec; 32(9):1542-7. PubMed ID: 22072265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intra-labyrinthine schwannomas: a report of two cases].
    Boutin P; Guth A; Bouccara D; el Garem H; Rey A; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 1998 Feb; 115(1):35-41. PubMed ID: 9765709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralabyrinthine schwannomas mimic cochleovestibular disease: symptoms from tumor mass effect in the labyrinth.
    Slattery EL; Babu SC; Chole RA; Zappia JJ
    Otol Neurotol; 2015 Jan; 36(1):167-71. PubMed ID: 25111524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracochlear schwannomas confined to the otic capsule.
    Jiang ZY; Kutz JW; Roland PS; Isaacson B
    Otol Neurotol; 2011 Sep; 32(7):1175-9. PubMed ID: 21817934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences to hearing during the conservative management of vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralabyrinthine schwannomas.
    Fitzgerald DC; Grundfast KM; Hecht DA; Mark AS
    Am J Otol; 1999 May; 20(3):381-5. PubMed ID: 10337982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation of intralabyrinthine schwannomas: a multicenter study of 110 cases.
    Dubernard X; Somers T; Veros K; Vincent C; Franco-Vidal V; Deguine O; Bordure P; Linder T; Lescanne E; Ayache D; Mondain M; Schmerber S; Dahmani-Causse M; Truy E; Darrouzet V
    Otol Neurotol; 2014 Oct; 35(9):1641-9. PubMed ID: 25098591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2.
    Lalwani AK; Abaza MM; Makariou EV; Armstrong M
    Am J Otol; 1998 May; 19(3):352-7. PubMed ID: 9596188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of intralabyrinthine schwannomas.
    Green JD; McKenzie JD
    Laryngoscope; 1999 Oct; 109(10):1626-31. PubMed ID: 10522933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing loss in Paget's disease: a temporal bone histopathology study.
    Dimitriadis PA; Bamiou DE; Bibas AG
    Otol Neurotol; 2012 Feb; 33(2):142-6. PubMed ID: 22222574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal bone pathology in intracochlear schwannoma with profound hearing loss.
    Ohtani I; Suzuki C; Aikawa T
    Auris Nasus Larynx; 1990; 17(1):17-22. PubMed ID: 2390029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical acumen and vestibular schwannoma.
    Moffat DA; Baguley DM; Beynon GJ; Da Cruz M
    Am J Otol; 1998 Jan; 19(1):82-7. PubMed ID: 9455955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR findings in intralabyrinthine schwannomas.
    Montague ML; Kishore A; Hadley DM; O'Reilly BF
    Clin Radiol; 2002 May; 57(5):355-8. PubMed ID: 12014931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic image (252). A woman with complaints of tinnitus, hearing loss and headache].
    te Lintelo MP; Koehler PJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2565. PubMed ID: 16320667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presbycusis: a human temporal bone study of individuals with downward sloping audiometric patterns of hearing loss and review of the literature.
    Nelson EG; Hinojosa R
    Laryngoscope; 2006 Sep; 116(9 Pt 3 Suppl 112):1-12. PubMed ID: 16946668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary inner ear schwannomas: a case series and systematic review of the literature.
    Van Abel KM; Carlson ML; Link MJ; Neff BA; Beatty CW; Lohse CM; Eckel LJ; Lane JI; Driscoll CL
    Laryngoscope; 2013 Aug; 123(8):1957-66. PubMed ID: 23335152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of vestibular dysfunction and hearing loss in intralabyrinthine schwannomas.
    Totten DJ; Manzoor NF; Perkins EL; Cass ND; Bennett ML; Haynes DS
    Am J Otolaryngol; 2021; 42(4):102984. PubMed ID: 33610925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different clinical presentation of intralabyrinthine schwannomas - a systematic review.
    Elias TGA; Perez Neto A; Zica ATS; Antunes ML; Penido NO
    Braz J Otorhinolaryngol; 2019; 85(1):111-120. PubMed ID: 29980446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of intralabyrinthine schwannomas.
    Di Lella F; Dispenza F; De Stefano A; Falcioni M; Sanna M
    Auris Nasus Larynx; 2007 Dec; 34(4):459-63. PubMed ID: 17467216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
    Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
    Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.